A Double-Blind, Randomized, Placebo-Controlled, Multicenter, 30-Night Polysomnographic Study of MK0928 in Adult Patients With Primary Insomnia

NCT00094627 Phase 3 COMPLETED

The purpose of the study is to test the safety and effectiveness of the Investigational Drug on insomnia.

Details

Lead sponsor	H. Lundbeck A/S
Phase	Phase 3
Status	COMPLETED
Enrolment	465
Start date	2004-11
Completion	2006-04

Conditions

• Primary Insomnia

Interventions

• gaboxadol
• Comparator: placebo (unspecified)

Primary outcomes

• Amount of time spent awake and time to fall asleep at night after 2 days — After 2 days